Search
News & Media About Us Health & Wellness Research & Development Our Brands Investors Community Careers
Adcock Ingram's Integrated Report 2012 Adcock Ingram's Group Audited Results 2012

Welcome to Adcock Ingram

Thank you for accessing Adcock Ingram's corporate website. Our website offers a diverse range of information about our Company to help give you an understanding of who we are and what we have to offer.
Please contact us should you require any further information.
Jonathan Louw (CEO Adcock Ingram)
Latest News
Adcock Ingram today announced that the Centre for Drug Evaluation and Research of the US Food and Drug Administration has accredited the company’s Wadeville Manufacturing facility,
Health Awareness Events
22
May
Wednesday
Su
Mo
Tu
We
Th
Fr
Sa
28
29
30
2
3
4
5
6
7
9
11
13
14
16
17
18
19
20
21
22
30
1
Financial Indicators
Latest Share Price
6650 cents
Percentage Change: -1.16
Code: AIP
PE Ratio: 16.12
EY: 6.20
DY: 2.96
ZAR/USD: 9.5497
Interim Dividend (cents): 115.00
Final Dividend (cents): 86.00
BBBEE In Action
Powered By Krew
Contact Us Affiliations Disclaimer Glossary